These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32346304)

  • 21. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
    Hamada K; Uedo N; Tonai Y; Arao M; Suzuki S; Iwatsubo T; Kato M; Shichijo S; Yamasaki Y; Matsuura N; Nakahira H; Kanesaka T; Yamamoto S; Akasaka T; Hanaoka N; Takeuchi Y; Higashino K; Ishihara R; Okada H; Iishi H; Fukui K; Shimokawa T
    J Gastroenterol; 2019 Feb; 54(2):122-130. PubMed ID: 29943163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
    Tsuchiya I; Kato Y; Tanida E; Masui Y; Kato S; Nakajima A; Izumi M
    Dig Endosc; 2017 Jul; 29(5):576-583. PubMed ID: 28267236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases.
    Oshima T; Miwa H
    J Neurogastroenterol Motil; 2018 Jul; 24(3):334-344. PubMed ID: 29739175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis.
    Simadibrata DM; Syam AF; Lee YY
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2217-2228. PubMed ID: 36181401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations.
    Echizen H
    Clin Pharmacokinet; 2016 Apr; 55(4):409-18. PubMed ID: 26369775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis.
    Jiang X; Li J; Xie J; Liang Z; Wan N; Jiang J; Zhang T; Wu Y
    Front Pharmacol; 2019; 10():1055. PubMed ID: 31607912
    [No Abstract]   [Full Text] [Related]  

  • 27. Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.
    Sugano K
    Therap Adv Gastroenterol; 2018; 11():1756283X17745776. PubMed ID: 29383028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
    Otake K; Sakurai Y; Nishida H; Fukui H; Tagawa Y; Yamasaki H; Karashima M; Otsuka K; Inatomi N
    Adv Ther; 2016 Jul; 33(7):1140-57. PubMed ID: 27287852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Vonoprazan Compared with Esomeprazole on the Healing of Artificial Postendoscopic Submucosal Dissection Ulcers: A Prospective, Multicenter, Two-Arm, Randomized Controlled Trial.
    Ishii Y; Yamada H; Sato T; Sue S; Kaneko H; Irie K; Sasaki T; Tamura T; Ikeda R; Fukuchi T; Kobayashi R; Makazu M; Sato C; Hirasawa K; Kondo M; Shibata W; Maeda S
    Gastroenterol Res Pract; 2018; 2018():1615092. PubMed ID: 29670650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-based clinical practice guidelines for peptic ulcer disease 2020.
    Kamada T; Satoh K; Itoh T; Ito M; Iwamoto J; Okimoto T; Kanno T; Sugimoto M; Chiba T; Nomura S; Mieda M; Hiraishi H; Yoshino J; Takagi A; Watanabe S; Koike K
    J Gastroenterol; 2021 Apr; 56(4):303-322. PubMed ID: 33620586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study.
    Ban H; Inatomi O; Murata M; Otsuka T; Oi M; Matsumoto H; Bamba S; Andoh A
    J Clin Biochem Nutr; 2021 May; 68(3):259-263. PubMed ID: 34025030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vonoprazan 20 mg
    Takahashi K; Sato Y; Kohisa J; Watanabe J; Sato H; Mizuno K; Hashimoto S; Terai S
    World J Gastrointest Endosc; 2016 Nov; 8(19):716-722. PubMed ID: 27909552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice.
    Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Mochizuki S; Matsuo K; Isomura Y; Seto M; Suzuki N; Suzuki H; Yamamoto S; Sugimoto T; Omae T; Okamoto M; Watabe H; Togo G; Takano N; Fukui K; Ito Y; Koike K
    J Dig Dis; 2016 Oct; 17(10):670-675. PubMed ID: 27534444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vonoprazan-based therapy for
    Akazawa Y; Fukuda D; Fukuda Y
    Therap Adv Gastroenterol; 2016 Nov; 9(6):845-852. PubMed ID: 27803739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vonoprazan fumarate for the management of acid-related diseases.
    Martinucci I; Blandizzi C; Bodini G; Marabotto E; Savarino V; Marchi S; de Bortoli N; Savarino E
    Expert Opin Pharmacother; 2017 Aug; 18(11):1145-1152. PubMed ID: 28657473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
    Jaruvongvanich V; Poonsombudlert K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1416-1421. PubMed ID: 29985791
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.